Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Hovione today announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol®
Manufacturing Chemist, 3 May 2023
Innovations in Pharmaceutical Technology, IPT Online, 27 October 2025
Silicon Republic, October 2, 2020
Safety First, Quality Always: We are continuously improving the safety of our operations with the patient’s safety in mind.
Hovione, the specialist integrated CDMO, just announced an expansion of its nasal drug delivery capabilities with the addition of a family of innovative nasal powder delivery devices developed in partnership with IDC.
Hovione reported today recent capacity expansion and future plans in its sites in Portugal, Ireland and New Jersey.
Make your drug soluble with Dispersome® technology. Dispersome® is a solubility enhancement technology that relies on an innovative and naturally occurring excipient to develop amorphous solid dispersions with high drug loading and high bioavailability.
Google Chrome
Safari
Firefox
Edge